3-methyl-N-[(3S)-7-methyl-4-oxo-5-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-2,3-dihydro-1,5-benzothiazepin-3-yl]-3-(1,3-oxazol-5-ylmethylamino)butanamide

C33H34N8O3S — CID 54556487

IUPAC3-methyl-N-[(3S)-7-methyl-4-oxo-5-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-2,3-dihydro-1,5-benzothiazepin-3-yl]-3-(1,3-oxazol-5-ylmethylamino)butanamide
SMILESCc1ccc2c(c1)N(Cc1ccc(-c3ccccc3-c3nn[nH]n3)cc1)C(=O)[C@H](NC(=O)CC(C)(C)NCc1cnco1)CS2
InChIInChI=1S/C33H34N8O3S/c1-21-8-13-29-28(14-21)41(18-22-9-11-23(12-10-22)25-6-4-5-7-26(25)31-37-39-40-38-31)32(43)27(19-45-29)36-30(42)15-33(2,3)35-17-24-16-34-20-44-24/h4-14,16,20,27,35H,15,17-19H2,1-3H3,(H,36,42)(H,37,38,39,40)/t27-/m1/s1
InChIKeyZNNCIWGHKCPLJI-HHHXNRCGSA-N
MW622.76 g/mol
LogP4.91
Rot. Bonds10

About 3-methyl-N-[(3S)-7-methyl-4-oxo-5-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-2,3-dihydro-1,5-benzothiazepin-3-yl]-3-(1,3-oxazol-5-ylmethylamino)butanamide

3-methyl-N-[(3S)-7-methyl-4-oxo-5-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-2,3-dihydro-1,5-benzothiazepin-3-yl]-3-(1,3-oxazol-5-ylmethylamino)butanamide (PubChem CID 54556487) has the molecular formula C33H34N8O3S and a molecular weight of 622.76 g/mol. Its IUPAC name is 3-methyl-N-[(3S)-7-methyl-4-oxo-5-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-2,3-dihydro-1,5-benzothiazepin-3-yl]-3-(1,3-oxazol-5-ylmethylamino)butanamide.

Molecular Properties

Compound Name3-methyl-N-[(3S)-7-methyl-4-oxo-5-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-2,3-dihydro-1,5-benzothiazepin-3-yl]-3-(1,3-oxazol-5-ylmethylamino)butanamide
PubChem CID54556487
Molecular FormulaC33H34N8O3S
Molecular Weight622.76 g/mol
Exact Mass622.25
IUPAC Name3-methyl-N-[(3S)-7-methyl-4-oxo-5-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-2,3-dihydro-1,5-benzothiazepin-3-yl]-3-(1,3-oxazol-5-ylmethylamino)butanamide
SMILESCc1ccc2c(c1)N(Cc1ccc(-c3ccccc3-c3nn[nH]n3)cc1)C(=O)[C@H](NC(=O)CC(C)(C)NCc1cnco1)CS2
InChIInChI=1S/C33H34N8O3S/c1-21-8-13-29-28(14-21)41(18-22-9-11-23(12-10-22)25-6-4-5-7-26(25)31-37-39-40-38-31)32(43)27(19-45-29)36-30(42)15-33(2,3)35-17-24-16-34-20-44-24/h4-14,16,20,27,35H,15,17-19H2,1-3H3,(H,36,42)(H,37,38,39,40)/t27-/m1/s1
InChIKeyZNNCIWGHKCPLJI-HHHXNRCGSA-N
XLogP4.91
TPSA141.93 Ų
H-Bond Donors3
H-Bond Acceptors9
Rotatable Bonds10
Heavy Atoms45
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500622.76
LogP ≤ 54.91
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 109

Analyze 3-methyl-N-[(3S)-7-methyl-4-oxo-5-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-2,3-dihydro-1,5-benzothiazepin-3-yl]-3-(1,3-oxazol-5-ylmethylamino)butanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-methyl-N-[(3S)-7-methyl-4-oxo-5-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-2,3-dihydro-1,5-benzothiazepin-3-yl]-3-(1,3-oxazol-5-ylmethylamino)butanamide?
The IUPAC name of 3-methyl-N-[(3S)-7-methyl-4-oxo-5-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-2,3-dihydro-1,5-benzothiazepin-3-yl]-3-(1,3-oxazol-5-ylmethylamino)butanamide (CID 54556487) is 3-methyl-N-[(3S)-7-methyl-4-oxo-5-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-2,3-dihydro-1,5-benzothiazepin-3-yl]-3-(1,3-oxazol-5-ylmethylamino)butanamide.
What is the SMILES notation for 3-methyl-N-[(3S)-7-methyl-4-oxo-5-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-2,3-dihydro-1,5-benzothiazepin-3-yl]-3-(1,3-oxazol-5-ylmethylamino)butanamide?
The canonical SMILES for 3-methyl-N-[(3S)-7-methyl-4-oxo-5-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-2,3-dihydro-1,5-benzothiazepin-3-yl]-3-(1,3-oxazol-5-ylmethylamino)butanamide is Cc1ccc2c(c1)N(Cc1ccc(-c3ccccc3-c3nn[nH]n3)cc1)C(=O)[C@H](NC(=O)CC(C)(C)NCc1cnco1)CS2.
What is the InChIKey of 3-methyl-N-[(3S)-7-methyl-4-oxo-5-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-2,3-dihydro-1,5-benzothiazepin-3-yl]-3-(1,3-oxazol-5-ylmethylamino)butanamide?
The InChIKey is ZNNCIWGHKCPLJI-HHHXNRCGSA-N. The full InChI is InChI=1S/C33H34N8O3S/c1-21-8-13-29-28(14-21)41(18-22-9-11-23(12-10-22)25-6-4-5-7-26(25)31-37-39-40-38-31)32(43)27(19-45-29)36-30(42)15-33(2,3)35-17-24-16-34-20-44-24/h4-14,16,20,27,35H,15,17-19H2,1-3H3,(H,36,42)(H,37,38,39,40)/t27-/m1/s1.
What are the key properties of 3-methyl-N-[(3S)-7-methyl-4-oxo-5-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-2,3-dihydro-1,5-benzothiazepin-3-yl]-3-(1,3-oxazol-5-ylmethylamino)butanamide?
3-methyl-N-[(3S)-7-methyl-4-oxo-5-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-2,3-dihydro-1,5-benzothiazepin-3-yl]-3-(1,3-oxazol-5-ylmethylamino)butanamide has a molecular weight of 622.76 g/mol, XLogP of 4.91, 10 rotatable bonds, 3 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for 3-methyl-N-[(3S)-7-methyl-4-oxo-5-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-2,3-dihydro-1,5-benzothiazepin-3-yl]-3-(1,3-oxazol-5-ylmethylamino)butanamide is sourced from PubChem (CID 54556487), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).